Balyasny Asset Management L.P.

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 1218710 Chicago, IL

Position in ACRS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$10,704,156

-$1,900,824 QoQ

Shares Held

2,023,470

-39.8% QoQ

Ownership

1.37%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#14

of 149 holders

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $2,351,657,469 across 178 Biotechnology names. ACRS ranks #66 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	1,665,102	$221,008,988
2	INSM	INSMED Inc	1,326,430	$141,423,966
3	BBIO	BridgeBio Pharma, Inc.	1,230,052	$91,614,272
4	ABVX	Abivax S.A.	603,840	$80,467,718
5	VRTX	Vertex Pharmaceuticals Inc / Ma	145,005	$72,028,333
6	TNGX	Tango Therapeutics, Inc.	2,016,379	$63,032,007
7	CYTK	Cytokinetics Inc	711,676	$60,627,678
8	BMRN	Biomarin Pharmaceutical Inc	1,054,613	$60,344,955

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,704,156	2,023,470	-39.8%	Shares	Sole	2026-08-14
2026-03-31	$12,604,980	3,361,328	+4667.7%	Shares	Sole	2026-05-15
2025-03-31	$107,868	70,502	+406.8%	Shares	Sole	2025-05-15
2024-06-30	$15,301	13,910	+32.3%	Shares	Sole	2024-08-14
2023-09-30	$72,000	10,511	-48.7%	Shares	Sole	2023-11-14
2022-12-31	$322,922	20,503	-80.7%	Shares	Sole	2023-02-14
2022-09-30	$1,670,753	106,147	-49.4%	Shares	Other	2022-11-15
2022-03-31	$3,614,124	209,636	-55.1%	Shares	Sole	2022-05-16
2021-12-31	$6,781,456	466,400	+188.2%	Shares	Sole	2022-02-14
2021-09-30	$2,913,174	161,843	+4.8%	Shares	Sole	2021-12-01
2021-06-30	$2,711,615	154,420	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.